SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-006811
Filing Date
2020-05-18
Accepted
2020-05-18 17:00:44
Documents
15
Period of Report
2020-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20200518x8k.htm   iXBRL 8-K 39523
2 EX-1.1 tgtx-20200514xex1d1.htm EX-1.1 302322
3 EX-5.1 tgtx-20200514xex5d1.htm EX-5.1 34718
4 GRAPHIC tgtx-20200514xex5d1g001.jpg GRAPHIC 22275
  Complete submission text file 0001558370-20-006811.txt   594553

Data Files

Seq Description Document Type Size
5 EX-101.SCH tgtx-20200518.xsd EX-101.SCH 2698
6 EX-101.LAB tgtx-20200518_lab.xml EX-101.LAB 16172
7 EX-101.PRE tgtx-20200518_pre.xml EX-101.PRE 11165
15 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20200518x8k_htm.xml XML 4829
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 20890438
SIC: 2834 Pharmaceutical Preparations